All In Biotech

Free tool

FAERS Monitor: Invokamet

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 204353 or its brand name (Invokamet, Canagliflozin, Metformin Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

1,695

Serious

965

57% of reports

Hospitalization

609

Death reported

21

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • osteomyelitis197
  • toe amputation192
  • diabetic ketoacidosis161
  • acute kidney injury101
  • cellulitis92
  • diabetic foot infection84
  • blood glucose increased80
  • gangrene80
  • nausea74
  • off label use73
  • diarrhoea71
  • weight decreased66
  • diabetic foot63
  • leg amputation62
  • foot amputation59

Reports by year received

View as table
YearReports
20146
2015292
2016350
2017255
2018350
2019185
202093
202147
202232
202334
202427
202513
202611

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,464 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
diabetic foot infectionSignal84782.7631.160,960
foot amputationSignal59524.6406.029,083
toe amputationSignal192487.6425.589,262
diabetic footSignal63260.7204.115,715
leg amputationSignal62189.5148.211,270
gangreneSignal80166.9134.612,861
osteomyelitisSignal197136.5119.626,105
diabetic ketoacidosisSignal16183.772.213,005
cellulitisSignal9222.718.61,887
acute kidney injurySignal1018.26.8635
blood glucose increasedSignal805.34.3275
weight decreasedSignal662.92.383
diarrhoea711.41.17
nausea741.20.92
off label use731.00.80

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.